| API | CAS# | Quality Standard | Status |
| Hydrochlorothiazide | 58-93-5 | USP；EP；CP | CEP, DMF, GMP |
| Indapamide | 26807-65-8 | USP；EP；CP | CEP, DMF, GMP |
| Dacarbazine | 4342-03-4 | USP；EP；CP | CEP, DMF, GMP |
| Idebenone | 58186-27-9 | CP;In-house | DMF(032079), GMP |
| Oxaliplatin | 61825-94-3 | USP；EP；CP | DMF, GMP |
| Fasudil hydrochloride | 105628-07-7 | CP | GMP |
| Clopidogrel Bisulfate | 120202-66-6 | USP；EP；CP | DMF, GMP |
| Esomeprazole sodium | 161796-78-7 | In-house | GMP |
| Tenofovir Disoproxil Fumarate | 202138-50-9 | CP | GMP |
| Pemetrexed Disodium | 357166-30-4 | USP；EP；In-house | DMF (#25640),GMP(Y20170000046) |
| Imatinib mesylate | 220127-57-1 | EP；In-house | GMP(Y20170000972) |
| Capecitabine | 154361-50-9 | USP；EP；In-house | GMP(Y20170000125) |
| Bortezomib | 390800-88-1 | In-house | GMP(Y20170000768),DMF |
| Gefitinib | 184475-35-2 | EP；In-house | GMP(Y20180001631),DMF |
| Temozolomide? | 85622-93-1 | USP；EP；In-house | GMP(Y20170000549),DMF |
| Esomeprazole Magnesium | 217087-09-7 | USP；In-house | GMP(Y20170001661) |
| Erlotinib HCl | 183319-69-9 | In-house | GMP(Y20180000977) |
| Nilotinib HCl | 923288-90-8 | In-house | DMF (#031693) |
| Ticagrelor | 274693-27-5 | In-house | GMP in process,DMF |
| Bazedoxifene Acetate | 198481-33-3 | In-house | R&D |
| Afatinib diMaleate | 850140-73-7 | In-house | R&D |
Chinese
English